| 1 | [SID103170545] | Active | IC50 | 0.0054 | Cytotoxicity against human HepG2 cells assessed as inhibition of [3H]thymidine after 48 hrs [AID326456, Type: Literature] | |   View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 103170545 | | CID | 97226 | | Outcome | Active | | IC50 | 0.0054 [uM] | | BioAssay | Cytotoxicity against human HepG2 cells assessed as inhibition of [3H]thymidine after 48 hrs | | AID | 326456 | | BioAssay type | Literature | | Target | | | PubMed | 18318465 | | Data Table |  |
|
| 2 | [SID103170545] | Active | IC50 | 0.0069 | Cytotoxicity against human H298 cells assessed as inhibition of [3H]thymidine after 48 hrs [AID326459, Type: Literature] | |   View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 103170545 | | CID | 97226 | | Outcome | Active | | IC50 | 0.0069 [uM] | | BioAssay | Cytotoxicity against human H298 cells assessed as inhibition of [3H]thymidine after 48 hrs | | AID | 326459 | | BioAssay type | Literature | | Target | | | PubMed | 18318465 | | Data Table |  |
|
| 3 | [SID103170545] | Active | IC50 | 0.0088 | Cytotoxicity against human HT29 cells assessed as inhibition of [3H]thymidine after 48 hrs [AID326458, Type: Literature] | |   View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 103170545 | | CID | 97226 | | Outcome | Active | | IC50 | 0.0088 [uM] | | BioAssay | Cytotoxicity against human HT29 cells assessed as inhibition of [3H]thymidine after 48 hrs | | AID | 326458 | | BioAssay type | Literature | | Target | | | PubMed | 18318465 | | Data Table |  |
|
| 4 | [SID103170545] | Active | IC50 | 0.0091 | Cytotoxicity against human Colo 205 cells assessed as inhibition of [3H]thymidine after 48 hrs [AID326457, Type: Literature] | |   View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 103170545 | | CID | 97226 | | Outcome | Active | | IC50 | 0.0091 [uM] | | BioAssay | Cytotoxicity against human Colo 205 cells assessed as inhibition of [3H]thymidine after 48 hrs | | AID | 326457 | | BioAssay type | Literature | | Target | | | PubMed | 18318465 | | Data Table |  |
|
| 5 | [SID103170545] | Active | IC50 | 0.012 | Inhibitory activity against P388 Leukemia cells [AID150662, Type: Literature] | |   View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 103170545 | | CID | 97226 | | Outcome | Active | | IC50 | 0.012 [uM] | | BioAssay | Inhibitory activity against P388 Leukemia cells | | AID | 150662 | | BioAssay type | Literature | | Target | | | PubMed | 12565975 | | Data Table |  |
|
| 6 | [SID103170545] | Active | IC50 | 0.018 | Inhibitory activity in mice bearing L1210 leukemia [AID100463, Type: Literature] | |   View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 103170545 | | CID | 97226 | | Outcome | Active | | IC50 | 0.018 [uM] | | BioAssay | Inhibitory activity in mice bearing L1210 leukemia | | AID | 100463 | | BioAssay type | Literature | | Target | | | PubMed | 1846923 | | Data Table |  |
|
| 7 | [SID50107786] | Active | Potency | 0.0184 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT [AID686979, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 50107786 | | CID | 97226 | | Outcome | Active | | Potency | 0.0184 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT | | AID | 686979 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 8 | [SID50107786] | Active | Potency | 0.0184 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT [AID686979, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 50107786 | | CID | 97226 | | Outcome | Active | | Potency | 0.0184 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT | | AID | 686979 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 9 | [SID50107786] | Active | Potency | 0.0184 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT [AID686979, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 50107786 | | CID | 97226 | | Outcome | Active | | Potency | 0.0184 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT | | AID | 686979 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 10 | [SID26750003] | Active | Potency | 0.0206 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT [AID686979, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 26750003 | | CID | 97226 | | Outcome | Active | | Potency | 0.0206 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT | | AID | 686979 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 11 | [SID26750003] | Active | Potency | 0.0206 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT [AID686979, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 26750003 | | CID | 97226 | | Outcome | Active | | Potency | 0.0206 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT | | AID | 686979 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 12 | [SID26750003] | Active | Potency | 0.0206 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT [AID686979, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 26750003 | | CID | 97226 | | Outcome | Active | | Potency | 0.0206 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT | | AID | 686979 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 13 | [SID103170545] | Active | IC50 | 0.03 | Cytotoxicity against human Jurkat cells after 48 hrs by MTT assay [AID481528, Type: Literature] | |   View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 103170545 | | CID | 97226 | | Outcome | Active | | IC50 | 0.03 [uM] | | BioAssay | Cytotoxicity against human Jurkat cells after 48 hrs by MTT assay | | AID | 481528 | | BioAssay type | Literature | | Target | | | PubMed | 20402524 | | Data Table |  |
|
| 14 | [SID103170545] | Active | IC50 | 0.0312 | Cytotoxicity against human HCT116 after 72 hrs by SRB assay [AID666763, Type: Literature] | |   View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 103170545 | | CID | 97226 | | Outcome | Active | | IC50 | 0.0312 [uM] | | BioAssay | Cytotoxicity against human HCT116 after 72 hrs by SRB assay | | AID | 666763 | | BioAssay type | Literature | | Target | | | PubMed | 22647222 | | Data Table |  |
|
| 15 | [SID103170545] | Active | IC50 | 0.0336 | Cytotoxicity against human A549 after 72 hrs by SRB assay [AID666764, Type: Literature] | |   View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 103170545 | | CID | 97226 | | Outcome | Active | | IC50 | 0.0336 [uM] | | BioAssay | Cytotoxicity against human A549 after 72 hrs by SRB assay | | AID | 666764 | | BioAssay type | Literature | | Target | | | PubMed | 22647222 | | Data Table |  |
|
| 16 | [SID103170545] | Active | GI50 | 0.036 | Mean GI50 against variety of human tumor cell lines [AID222948, Type: other] | |  View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 103170545 | | CID | 97226 | | Outcome | Active | | GI50 | 0.036 [uM] | | BioAssay | Mean GI50 against variety of human tumor cell lines | | AID | 222948 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 17 | [SID103170545] | Active | IC50 | 0.04 | Cytotoxicity against human HL60 cells after 48 hrs by MTT assay [AID481527, Type: Literature] | |   View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 103170545 | | CID | 97226 | | Outcome | Active | | IC50 | 0.04 [uM] | | BioAssay | Cytotoxicity against human HL60 cells after 48 hrs by MTT assay | | AID | 481527 | | BioAssay type | Literature | | Target | | | PubMed | 20402524 | | Data Table |  |
|
| 18 | [SID50107786] | Active | Potency | 0.0517 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT [AID686978, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 50107786 | | CID | 97226 | | Outcome | Active | | Potency | 0.0517 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT | | AID | 686978 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 19 | [SID50107786] | Active | Potency | 0.0517 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT [AID686978, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 50107786 | | CID | 97226 | | Outcome | Active | | Potency | 0.0517 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT | | AID | 686978 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 20 | [SID50107786] | Active | Potency | 0.0517 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT [AID686978, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 50107786 | | CID | 97226 | | Outcome | Active | | Potency | 0.0517 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT | | AID | 686978 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 21 | [SID26750003] | Active | Potency | 0.058 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT [AID686978, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 26750003 | | CID | 97226 | | Outcome | Active | | Potency | 0.058 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT | | AID | 686978 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 22 | [SID26750003] | Active | Potency | 0.058 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT [AID686978, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 26750003 | | CID | 97226 | | Outcome | Active | | Potency | 0.058 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT | | AID | 686978 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 23 | [SID26750003] | Active | Potency | 0.058 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT [AID686978, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 26750003 | | CID | 97226 | | Outcome | Active | | Potency | 0.058 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT | | AID | 686978 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 24 | [SID103170545] | Active | IC50 | 0.11 | Inhibition of Topoisomerase I by cleavage complex formation in human HL-60 cells [AID210946, Type: Literature] | |   View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 103170545 | | CID | 97226 | | Outcome | Active | | IC50 | 0.11 [uM] | | BioAssay | Inhibition of Topoisomerase I by cleavage complex formation in human HL-60 cells | | AID | 210946 | | BioAssay type | Literature | | Target | | | PubMed | 8410981 | | Data Table |  |
|
| 25 | [SID103170545] | Active | IC50 | 0.11 | Cytotoxicity against human U937 cells after 48 hrs by MTT assay [AID481529, Type: Literature] | |   View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 103170545 | | CID | 97226 | | Outcome | Active | | IC50 | 0.11 [uM] | | BioAssay | Cytotoxicity against human U937 cells after 48 hrs by MTT assay | | AID | 481529 | | BioAssay type | Literature | | Target | | | PubMed | 20402524 | | Data Table |  |
|
| 26 | [SID103170545] | Active | IC50 | 0.11 | Antitumor activity against human A549/ATCC cells by SRB method [AID426062, Type: Literature] | |   View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 103170545 | | CID | 97226 | | Outcome | Active | | IC50 | 0.11 [uM] | | BioAssay | Antitumor activity against human A549/ATCC cells by SRB method | | AID | 426062 | | BioAssay type | Literature | | Target | | | PubMed | 19541483 | | Data Table |  |
|
| 27 | [SID103170545] | Active | IC50 | 0.14 | Growth inhibition of human SMMC7721 cells after 48 hrs by MTT assay [AID468115, Type: Literature] | |   View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 103170545 | | CID | 97226 | | Outcome | Active | | IC50 | 0.14 [uM] | | BioAssay | Growth inhibition of human SMMC7721 cells after 48 hrs by MTT assay | | AID | 468115 | | BioAssay type | Literature | | Target | | | PubMed | 19842682 | | Data Table |  |
|
| 28 | [SID103170545] | Active | IC50 | 0.148 | Inhibitory concentration against human HCT116 colon cancer cell line [AID247623, Type: Literature] | |   View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 103170545 | | CID | 97226 | | Outcome | Active | | IC50 | 0.148 [uM] | | BioAssay | Inhibitory concentration against human HCT116 colon cancer cell line | | AID | 247623 | | BioAssay type | Literature | | Target | | | PubMed | 15808456 | | Data Table |  |
|
| 29 | [SID103170545] | Active | IC50 | 0.16 | Cytotoxicity against human K562 cells after 72 hrs by MTT assay [AID477404, Type: Literature] | |   View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 103170545 | | CID | 97226 | | Outcome | Active | | IC50 | 0.16 [uM] | | BioAssay | Cytotoxicity against human K562 cells after 72 hrs by MTT assay | | AID | 477404 | | BioAssay type | Literature | | Target | | | PubMed | 20184290 | | Data Table |  |
|
| 30 | [SID103170545] | Active | IC50 | 0.2 | Cytotoxicity against human Bel7402 cells after 48 hrs by MTT assay [AID431814, Type: Literature] | |   View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 103170545 | | CID | 97226 | | Outcome | Active | | IC50 | 0.2 [uM] | | BioAssay | Cytotoxicity against human Bel7402 cells after 48 hrs by MTT assay | | AID | 431814 | | BioAssay type | Literature | | Target | | | PubMed | 19715319 | | Data Table |  |
|
| 31 | [SID103170545] | Active | IC50 | 0.21 | Antitumor activity against human HT-29 cells by SRB method [AID426063, Type: Literature] | |   View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 103170545 | | CID | 97226 | | Outcome | Active | | IC50 | 0.21 [uM] | | BioAssay | Antitumor activity against human HT-29 cells by SRB method | | AID | 426063 | | BioAssay type | Literature | | Target | | | PubMed | 19541483 | | Data Table |  |
|
| 32 | [SID103170545] | Active | IC50 | 0.23 | Antitumor against human GLC82 cells assessed as cell survival after 48 hrs by MTT assay [AID611122, Type: Literature] | |   View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 103170545 | | CID | 97226 | | Outcome | Active | | IC50 | 0.23 [uM] | | BioAssay | Antitumor against human GLC82 cells assessed as cell survival after 48 hrs by MTT assay | | AID | 611122 | | BioAssay type | Literature | | Target | | | PubMed | 21600681 | | Data Table |  |
|
| 33 | [SID103170545] | Active | IC50 | 0.28 | Cytotoxicity against human Bel-7402 cells after 72 hrs by sulforhodamine B assay [AID379166, Type: Literature] | |   View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 103170545 | | CID | 97226 | | Outcome | Active | | IC50 | 0.28 [uM] | | BioAssay | Cytotoxicity against human Bel-7402 cells after 72 hrs by sulforhodamine B assay | | AID | 379166 | | BioAssay type | Literature | | Target | | | PubMed | 17067169 | | Data Table |  |
|
| 34 | [SID103170545] | Active | IC50 | 0.36 | Cytotoxicity against human Bel7402 cells after 72 hrs by SRB assay [AID477406, Type: Literature] | |   View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 103170545 | | CID | 97226 | | Outcome | Active | | IC50 | 0.36 [uM] | | BioAssay | Cytotoxicity against human Bel7402 cells after 72 hrs by SRB assay | | AID | 477406 | | BioAssay type | Literature | | Target | | | PubMed | 20184290 | | Data Table |  |
|
| 35 | [SID103170545] | Active | IC50 | 0.37 | Cytotoxicity against human CNE2 cells after 48 hrs by MTT assay [AID436375, Type: Literature] | |   View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 103170545 | | CID | 97226 | | Outcome | Active | | IC50 | 0.37 [uM] | | BioAssay | Cytotoxicity against human CNE2 cells after 48 hrs by MTT assay | | AID | 436375 | | BioAssay type | Literature | | Target | | | PubMed | 19423199 | | Data Table |  |
|
| 36 | [SID103170545] | Active | IC50 | 0.4 | Cytotoxicity against human Bel7402 cells after 72 hrs by SRB assay [AID421696, Type: Literature] | |   View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 103170545 | | CID | 97226 | | Outcome | Active | | IC50 | 0.4 [uM] | | BioAssay | Cytotoxicity against human Bel7402 cells after 72 hrs by SRB assay | | AID | 421696 | | BioAssay type | Literature | | Target | | | PubMed | 19133759 | | Data Table |  |
|
| 37 | [SID103170545] | Active | IC50 | 0.41 | Cytotoxicity against human HL-60 cells after 72 hrs by MTT assay [AID379165, Type: Literature] | |   View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 103170545 | | CID | 97226 | | Outcome | Active | | IC50 | 0.41 [uM] | | BioAssay | Cytotoxicity against human HL-60 cells after 72 hrs by MTT assay | | AID | 379165 | | BioAssay type | Literature | | Target | | | PubMed | 17067169 | | Data Table |  |
|
| 38 | [SID103170545] | Active | IC50 | 0.496 | Antitumor activity against mouse C26 cells by WST-1 assay [AID591019, Type: Literature] | |   View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 103170545 | | CID | 97226 | | Outcome | Active | | IC50 | 0.496 [uM] | | BioAssay | Antitumor activity against mouse C26 cells by WST-1 assay | | AID | 591019 | | BioAssay type | Literature | | Target | | | PubMed | 21414778 | | Data Table |  |
|
| 39 | [SID103170545] | Active | IC50 | 0.6 | Cytotoxicity against human KB cells after 48 hrs by MTT assay [AID431812, Type: Literature] | |   View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 103170545 | | CID | 97226 | | Outcome | Active | | IC50 | 0.6 [uM] | | BioAssay | Cytotoxicity against human KB cells after 48 hrs by MTT assay | | AID | 431812 | | BioAssay type | Literature | | Target | | | PubMed | 19715319 | | Data Table |  |
|
| 40 | [SID103170545] | Active | IC50 | 0.7 | Cytotoxicity against human A2780 cells after 48 hrs by MTT assay [AID431813, Type: Literature] | |   View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 103170545 | | CID | 97226 | | Outcome | Active | | IC50 | 0.7 [uM] | | BioAssay | Cytotoxicity against human A2780 cells after 48 hrs by MTT assay | | AID | 431813 | | BioAssay type | Literature | | Target | | | PubMed | 19715319 | | Data Table |  |
|
| 41 | [SID103170545] | Active | IC50 | 0.829 | Antitumor activity against human KB cells by WST-1 assay [AID591017, Type: Literature] | |   View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 103170545 | | CID | 97226 | | Outcome | Active | | IC50 | 0.829 [uM] | | BioAssay | Antitumor activity against human KB cells by WST-1 assay | | AID | 591017 | | BioAssay type | Literature | | Target | | | PubMed | 21414778 | | Data Table |  |
|
| 42 | [SID103170545] | Active | IC50 | 0.981 | Antitumor activity against human HepG2 cells by WST-1 assay [AID591018, Type: Literature] | |   View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 103170545 | | CID | 97226 | | Outcome | Active | | IC50 | 0.981 [uM] | | BioAssay | Antitumor activity against human HepG2 cells by WST-1 assay | | AID | 591018 | | BioAssay type | Literature | | Target | | | PubMed | 21414778 | | Data Table |  |
|
| 43 | [SID103170545] | Active | CC50 | 1 | Cytotoxicity against DNA topoisomerase I purified from calf thymus [AID56562, Type: Literature] | |   View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 103170545 | | CID | 97226 | | Outcome | Active | | CC50 | 1 [uM] | | BioAssay | Cytotoxicity against DNA topoisomerase I purified from calf thymus | | AID | 56562 | | BioAssay type | Literature | | Target | | | PubMed | 1846923 | | Data Table |  |
|
| 44 | [SID103170545] | Active | IC50 | 1.04 | Antitumor against human CNE2 cells assessed as cell survival after 48 hrs by MTT assay [AID611121, Type: Literature] | |   View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 103170545 | | CID | 97226 | | Outcome | Active | | IC50 | 1.04 [uM] | | BioAssay | Antitumor against human CNE2 cells assessed as cell survival after 48 hrs by MTT assay | | AID | 611121 | | BioAssay type | Literature | | Target | | | PubMed | 21600681 | | Data Table |  |
|
| 45 | [SID103170545] | Active | IC50 | 1.09 | Cytotoxicity against human GLC82 cells after 48 hrs by MTT assay [AID436376, Type: Literature] | |   View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 103170545 | | CID | 97226 | | Outcome | Active | | IC50 | 1.09 [uM] | | BioAssay | Cytotoxicity against human GLC82 cells after 48 hrs by MTT assay | | AID | 436376 | | BioAssay type | Literature | | Target | | | PubMed | 19423199 | | Data Table |  |
|
| 46 | [SID103170545] | Active | IC50 | 2.47 | Inhibitory concentration against human Bel-7402 liver cancer cell line [AID247637, Type: Literature] | |   View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 103170545 | | CID | 97226 | | Outcome | Active | | IC50 | 2.47 [uM] | | BioAssay | Inhibitory concentration against human Bel-7402 liver cancer cell line | | AID | 247637 | | BioAssay type | Literature | | Target | | | PubMed | 15808456 | | Data Table |  |
|
| 47 | [SID103170545] | Active | IC50 | 3.7 | Cytotoxicity against human HepG2 cells after 48 hrs by MTT assay [AID481526, Type: Literature] | |   View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 103170545 | | CID | 97226 | | Outcome | Active | | IC50 | 3.7 [uM] | | BioAssay | Cytotoxicity against human HepG2 cells after 48 hrs by MTT assay | | AID | 481526 | | BioAssay type | Literature | | Target | | | PubMed | 20402524 | | Data Table |  |
|
| 48 | [SID103170545] | Active | IC50 | 4.1 | Cytotoxicity against human K562 cells after 72 hrs by MTT assay [AID421695, Type: Literature] | |   View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 103170545 | | CID | 97226 | | Outcome | Active | | IC50 | 4.1 [uM] | | BioAssay | Cytotoxicity against human K562 cells after 72 hrs by MTT assay | | AID | 421695 | | BioAssay type | Literature | | Target | | | PubMed | 19133759 | | Data Table |  |
|
| 49 | [SID103170545] | Active | IC50 | 6.49 | Cytotoxicity against human Hep G2 after 48 hrs by MTT assay [AID378061, Type: Literature] | |   View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 103170545 | | CID | 97226 | | Outcome | Active | | IC50 | 6.49 [uM] | | BioAssay | Cytotoxicity against human Hep G2 after 48 hrs by MTT assay | | AID | 378061 | | BioAssay type | Literature | | Target | | | PubMed | 16933867 | | Data Table |  |
|
| 50 | [SID26750003] | Active | Potency | 10 | qHTS Assay for Identifying the Cell-Membrane Permeable IMPase Inhibitors: Potentiation with Lithium [AID1457, Type: confirmatory] | Inositol monophosphatase [gi:44888968] |  View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 26750003 | | CID | 97226 | | Outcome | Active | | Potency | 10 [uM] | | BioAssay | qHTS Assay for Identifying the Cell-Membrane Permeable IMPase Inhibitors: Potentiation with Lithium | | AID | 1457 | | BioAssay type | confirmatory | | Target | Inositol monophosphatase [gi:44888968] | | PubMed | | | Data Table |  |
|